Dr. DEEKSHA THORAT

Dr. MEHUL SHAH, Dr. SHREYA SHAH, Dr. RUHI GUNAY

Abstract

INTRODUCTION: CRVO IS IMPORTANT CAUSE OF BLINDNESS . WE DID A COMPARATIVE STUDY TO SEE THE EFFECT OF ANTI VEGF AND TRIAMCINOLONE ON VISUAL OUTCOME

METHOD: A RETROSPECTIVE COHORT STUDY WAS CONDUCTED OF LAST FIVE YEARS AT TERTIARY EYE CARE CENTER. ALL EYES WERE TREATED WITH MEDICAL AND LASER THERAPY.FORMAT WAS CREATED AND DATA WAS RETRIEVED FROM EMR AND ANALYSED WITH SPSS 22. DESCRIPTIVE AND CROSS TABULATION METHOD USED FOR ANALYSES. P VALUE <0.05 CONSIDERED STASTICALLY SIGNIFICANT. RESULT: OUR COHORT INCLUDED 105 EYES OUT OF WHICH 66.7%, 33.3 % M:F.MEAN AGE 55.9 YEARS. ON PRESENTATION MEAN CMT 319.8 AND MEAN RNFL 84.2. POST TREATMENT MEAN CMT 292.5 AND MEAN RNFL 96 EYES.WHEN WE COMPARED VISUAL OUTCOME AMONGST ANTI VEGF AND TRIMCINOLONE GROUP WE DID NOT FIND SIGNIFICANT DIFFERENCE. (P=0.26) CONCLUSION: INTRAVITREAL TRIAMCINOLONE IS ECONOMICAL FOR PATIENTS WITH CRVO AS NO SIGNIFICANCE DIFFERENCE WAS FOUND IN THE VISUAL OUTCOMES AFTER TREATMENT WITH ANTI-VEGF AND TRIAMCINOLONE. [advanced_iframe src="https://view.officeapps.live.com/op/embed.aspx?src=https://aiosproceedings.s3.ap-southeast-1.amazonaws.com/2021/E-Poster/FP382.pptx" width="100%" height="608"]